FDA cleared the AutoDensity from Eos Imaging on Nov 14, 2025 under K251078, a traditional 510(k). The device falls under product code QIH, Automated Radiological Image Processing Software, regulated at 21 CFR 892.2050 as a Class 2 device. The review panel was Radiology.
FDA logged the submission as received on Apr 8, 2025. The decision came 220 days later, longer than the 90 FDA-day review goal, which usually means at least one additional information request.
This is the only decision on file for Eos Imaging in the last 12 months of the tracker.